Hangzhou Tigermed Consulting Co., Ltd. (HNGZY)
USD 4.0
(0.0%)
USD 4.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 166.5 Million USD | 6.54% |
| 2022 | 156.28 Million USD | 9.51% |
| 2021 | 142.72 Million USD | 52.99% |
| 2020 | 93.28 Million USD | 11.75% |
| 2019 | 83.47 Million USD | -81.91% |
| 2018 | 461.39 Million CNY | 43.24% |
| 2017 | 322.12 Million CNY | 20.26% |
| 2016 | 267.85 Million CNY | 32.22% |
| 2015 | 202.57 Million CNY | 54.44% |
| 2014 | 131.17 Million CNY | 119.55% |
| 2013 | 59.74 Million CNY | 8.26% |
| 2012 | 55.18 Million CNY | 50.96% |
| 2011 | 36.55 Million CNY | 51.74% |
| 2010 | 24.09 Million CNY | 39.15% |
| 2009 | 17.31 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 276.4 Million CNY | -19.36% |
| 2024 Q1 | 279.75 Million CNY | 31.26% |
| 2024 Q2 | 296.76 Million CNY | -2.97% |
| 2023 Q2 | 287.4 Million CNY | 553.13% |
| 2023 FY | 166.5 Million USD | 6.54% |
| 2023 Q1 | 44 Million USD | 37.95% |
| 2023 Q4 | 226.14 Million CNY | -23.85% |
| 2023 Q3 | 296.96 Million CNY | 3.32% |
| 2022 Q3 | 32.84 Million USD | -86.83% |
| 2022 Q4 | 31.89 Million USD | -2.89% |
| 2022 Q2 | 249.48 Million CNY | 4.58% |
| 2022 Q1 | 238.55 Million CNY | 1.17% |
| 2022 FY | 156.28 Million USD | 9.51% |
| 2021 Q2 | 30.87 Million CNY | 10.77% |
| 2021 FY | 142.72 Million USD | 52.99% |
| 2021 Q3 | 221.14 Million CNY | 616.25% |
| 2021 Q4 | 235.78 Million CNY | 6.62% |
| 2021 Q1 | 27.87 Million CNY | -84.71% |
| 2020 Q2 | 153.55 Million CNY | 8.36% |
| 2020 Q3 | 157.11 Million CNY | 2.32% |
| 2020 Q4 | 182.35 Million CNY | 16.07% |
| 2020 FY | 93.28 Million USD | 11.75% |
| 2020 Q1 | 141.7 Million CNY | -16.5% |
| 2019 Q3 | 130.82 Million CNY | 4.7% |
| 2019 Q4 | 169.7 Million CNY | 29.72% |
| 2019 FY | 83.47 Million USD | -81.91% |
| 2019 Q1 | 126.47 Million CNY | -2.12% |
| 2019 Q2 | 124.95 Million CNY | -1.2% |
| 2018 Q1 | 107.82 Million CNY | 16.37% |
| 2018 FY | 461.39 Million CNY | 43.24% |
| 2018 Q3 | 115.37 Million CNY | 5.86% |
| 2018 Q4 | 129.2 Million CNY | 11.99% |
| 2018 Q2 | 108.98 Million CNY | 1.08% |
| 2017 Q3 | 82.03 Million CNY | 21.34% |
| 2017 FY | 322.12 Million CNY | 20.26% |
| 2017 Q4 | 92.65 Million CNY | 12.94% |
| 2017 Q2 | 67.6 Million CNY | -15.29% |
| 2017 Q1 | 79.81 Million CNY | 9.48% |
| 2016 Q1 | 66.18 Million CNY | 47.04% |
| 2016 Q2 | 58.44 Million CNY | -11.71% |
| 2016 FY | 267.85 Million CNY | 32.22% |
| 2016 Q4 | 72.9 Million CNY | 3.68% |
| 2016 Q3 | 70.31 Million CNY | 20.32% |
| 2015 Q2 | 49.27 Million CNY | -9.59% |
| 2015 Q3 | 53.77 Million CNY | 9.13% |
| 2015 Q4 | 45.01 Million CNY | -16.3% |
| 2015 Q1 | 54.5 Million CNY | 36.22% |
| 2015 FY | 202.57 Million CNY | 54.44% |
| 2014 Q2 | 23.91 Million CNY | -3.45% |
| 2014 Q1 | 24.76 Million CNY | 34.66% |
| 2014 FY | 131.17 Million CNY | 119.55% |
| 2014 Q4 | 40.01 Million CNY | -5.81% |
| 2014 Q3 | 42.48 Million CNY | 77.66% |
| 2013 FY | 59.74 Million CNY | 8.26% |
| 2013 Q1 | 14.09 Million CNY | -6.49% |
| 2013 Q3 | 13.59 Million CNY | -0.57% |
| 2013 Q4 | 18.39 Million CNY | 35.32% |
| 2013 Q2 | 13.66 Million CNY | -3.04% |
| 2012 Q1 | 11.41 Million CNY | 23.15% |
| 2012 Q3 | 16.86 Million CNY | 42.51% |
| 2012 Q4 | 15.07 Million CNY | -10.59% |
| 2012 FY | 55.18 Million CNY | 50.96% |
| 2012 Q2 | 11.83 Million CNY | 3.62% |
| 2011 Q3 | 10.38 Million CNY | 0.0% |
| 2011 Q4 | 9.27 Million CNY | -10.68% |
| 2011 FY | 36.55 Million CNY | 51.74% |
| 2010 FY | 24.09 Million CNY | 39.15% |
| 2009 FY | 17.31 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -15772.377% |
| Arrayit Corporation | 6.19 Million USD | -2586.554% |
| Atlantic International Corp. | 5.57 Million USD | -2884.816% |
| Biocept, Inc. | 29.4 Million USD | -466.311% |
| Bioqual, Inc. | 7.44 Million USD | -2135.285% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -21463.552% |
| DermTech, Inc. | 104.01 Million USD | -60.074% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | -635.96% |
| iMD Companies, Inc. | 151.8 Thousand USD | -109578.108% |
| IDenta Corp. | 662.97 Thousand USD | -25014.256% |
| Interpace Biosciences, Inc. | 20.23 Million USD | -722.96% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -428132.913% |
| InVitro International | 661.32 Thousand USD | -25076.954% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | -2245.749% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -286417.826% |
| Medical Imaging Corp. | 1.91 Million USD | -8607.477% |
| NovelStem International Corp. | 3.53 Million USD | -4606.351% |
| Optigenex Inc. | 1.28 Million USD | -12828.43% |
| PharmChem, Inc. | 2.93 Million USD | -5580.254% |
| Proteome Sciences plc | 3.26 Million USD | -4994.897% |
| Response Genetics, Inc | 25.31 Million USD | -557.614% |
| Rennova Health, Inc. | 7.67 Million USD | -2068.61% |
| RushNet, Inc. | 1.78 Million USD | -9205.28% |
| ScreenPro Security Inc. | 3.23 Million USD | -5040.652% |
| Stella Diagnostics Inc. | 11.42 Million USD | -1357.093% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | -2167.478% |
| Todos Medical Ltd. | 14.05 Million USD | -1084.388% |